Literature DB >> 314349

Zoonotic aspects of filarial infections in man.

A S Dissanaike.   

Abstract

This article gives an account of the filarial parasites found in man and their potential transmissibility to and from other vertebrate animals under natural and experimental conditions.Those species that are regarded as being primarily parasites of other vertebrates, but which also infect man, are then dealt with in greater detail. These include the subperiodic strain of Brugia malayi and perhaps also B. pahangi, both of which are found in wild and domestic carnivores and monkeys, and Dirofilaria species of dogs and racoons.The Brugia parasites develop to maturity with the production of microfilaraemia and clinical manifestations in man similar to those caused by periodic B. malayi in man. Human dirofilariasis, on the other hand, represents a transmission cul-de-sac for the parasite. Clinical manifestations are mild or absent and generally the worms do not mature and, even if they do, they rarely give rise to microfilaraemia. D. immitis causes pulmonary dirofilariasis, and D. repens and D. tenuis give rise to subcutaneous nodules in man. The diagnosis of dirofilariasis depends on an awareness of the infection in the animal reservoirs and of the possibility of man being exposed to bites of infected vectors.

Entities:  

Mesh:

Year:  1979        PMID: 314349      PMCID: PMC2395809     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Experimental infection of the long-tailed macaque, Macaca fasicularis with Wuchereria bancrofti (rural strain).

Authors:  A S Dissanaike; J W Mak
Journal:  Southeast Asian J Trop Med Public Health       Date:  1978-09       Impact factor: 0.267

2.  Histochemical differentiation of Brugia, Wuchereria, Dirofilaria and Breinlia microfilariae.

Authors:  P K Yen; J W Mak
Journal:  Ann Trop Med Parasitol       Date:  1978-04
  2 in total
  7 in total

1.  Ocular dirofilariosis in a Frenchwoman living in Sologne (France).

Authors:  M Therizol-Ferly; O Bain; F Reynouard; I Aimard; J M Raymond; C Rossazza; D Richard-Lenoble
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

2.  Acute lymphoblastic leukaemia with microfilaria: a rare coincidence in bone marrow aspirate.

Authors:  Ashok Kumar; Rakesh Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-07       Impact factor: 0.900

3.  Differential detection of Brugia malayi and Brugia pahangi by real-time fluorescence resonance energy transfer PCR and its evaluation for diagnosis of B. pahangi-infected dogs.

Authors:  Tongjit Thanchomnang; Pewpan M Intapan; Sudchit Chungpivat; Viraphong Lulitanond; Wanchai Maleewong
Journal:  Parasitol Res       Date:  2010-02       Impact factor: 2.289

4.  Draft genome of Brugia pahangi: high similarity between B. pahangi and B. malayi.

Authors:  Yee-Ling Lau; Wenn-Chyau Lee; Jinquan Xia; GuiPing Zhang; Rozaimi Razali; Arif Anwar; Mun-Yik Fong
Journal:  Parasit Vectors       Date:  2015-09-08       Impact factor: 3.876

5.  Exome and transcriptome sequencing of Aedes aegypti identifies a locus that confers resistance to Brugia malayi and alters the immune response.

Authors:  Punita Juneja; Cristina V Ariani; Yung Shwen Ho; Jewelna Akorli; William J Palmer; Arnab Pain; Francis M Jiggins
Journal:  PLoS Pathog       Date:  2015-03-27       Impact factor: 6.823

6.  Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?

Authors:  Chandana H Mallawarachchi; T G A Nilmini Chandrasena; Ranjan Premaratna; S M N S M Mallawarachchi; Nilanthi R de Silva
Journal:  Parasit Vectors       Date:  2018-01-29       Impact factor: 3.876

7.  A preliminary survey of filarial parasites in dogs and cats in Sri Lanka.

Authors:  Chandana H Mallawarachchi; Nilmini T G A Chandrasena; Susiji Wickramasinghe; Ranjan Premaratna; Nilmini Y I S Gunawardane; Navoda S M S M Mallawarachchi; Nilanthi R de Silva
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.